Drug
Fosaprepitant
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Helicobacter Infection | 210 | 259.7 | 296.3 | signal |
| 2 | Folliculitis | 207 | 252.5 | 287.5 | signal |
| 3 | Hand Deformity | 199 | 190.7 | 215.9 | signal |
| 4 | Pemphigus | 183 | 184.5 | 206.7 | signal |
| 5 | Autoimmune Disorder | 109 | 142.2 | 151.9 | signal |
| 6 | Pericarditis | 184 | 137.9 | 154.5 | signal |
| 7 | Synovitis | 177 | 122.3 | 136.4 | signal |
| 8 | Glossodynia | 211 | 117.7 | 134.2 | signal |
| 9 | Irritable Bowel Syndrome | 177 | 103.1 | 115.0 | signal |
| 10 | Hypercholesterolaemia | 75 | 97.6 | 102.0 | signal |
| 11 | Bursitis | 93 | 95.9 | 101.4 | signal |
| 12 | Wound Infection | 73 | 83.5 | 87.2 | signal |
| 13 | Laryngitis | 71 | 81.3 | 84.8 | signal |
| 14 | Wound | 179 | 80.0 | 89.3 | signal |
| 15 | Foot Deformity | 71 | 79.5 | 82.9 | signal |
| 16 | Impaired Healing | 199 | 75.3 | 85.2 | signal |
| 17 | Systemic Lupus Erythematosus | 185 | 64.9 | 72.7 | signal |
| 18 | Joint Range Of Motion Decreased | 68 | 63.1 | 65.7 | signal |
| 19 | Sciatica | 70 | 54.7 | 57.0 | signal |
| 20 | Contraindicated Product Administered | 130 | 53.4 | 57.8 | signal |
| 21 | Hepatic Cirrhosis | 79 | 52.4 | 54.9 | signal |
| 22 | Infusion Related Reaction | 277 | 52.0 | 61.9 | signal |
| 23 | Lower Respiratory Tract Infection | 185 | 50.6 | 56.7 | signal |
| 24 | Arthropathy | 205 | 45.5 | 51.7 | signal |
| 25 | Obesity | 58 | 45.0 | 46.6 | signal |
| 26 | Fibromyalgia | 88 | 44.9 | 47.3 | signal |
| 27 | Sleep Disorder Due To A General Medical Condition | 58 | 44.4 | 46.0 | signal |
| 28 | Blister | 200 | 44.2 | 50.0 | signal |
| 29 | Lower Limb Fracture | 68 | 44.1 | 45.9 | signal |
| 30 | Weight Fluctuation | 37 | 44.0 | 45.0 | signal |
| 31 | Pulmonary Fibrosis | 66 | 42.8 | 44.5 | signal |
| 32 | Discomfort | 208 | 42.5 | 48.3 | signal |
| 33 | Ill-defined Disorder | 201 | 41.0 | 46.3 | signal |
| 34 | Stomatitis | 199 | 40.6 | 45.9 | signal |
| 35 | Liver Injury | 77 | 39.4 | 41.3 | signal |
| 36 | Hepatic Enzyme Increased | 204 | 37.2 | 42.1 | signal |
| 37 | Prescribed Overdose | 55 | 35.2 | 36.3 | signal |
| 38 | Ear Infection | 74 | 34.5 | 36.0 | signal |
| 39 | Frequent Bowel Movements | 74 | 34.1 | 35.6 | signal |
| 40 | Delirium | 94 | 33.7 | 35.6 | signal |
| 41 | Type 2 Diabetes Mellitus | 81 | 29.7 | 31.1 | signal |
| 42 | Injury | 168 | 29.4 | 32.5 | signal |
| 43 | Hip Arthroplasty | 36 | 29.3 | 30.0 | signal |
| 44 | Gastrointestinal Disorder | 205 | 28.7 | 32.5 | signal |
| 45 | Contusion | 207 | 26.6 | 30.2 | signal |
| 46 | Laboratory Test Abnormal | 62 | 26.0 | 27.0 | signal |
| 47 | Joint Dislocation | 21 | 24.7 | 25.0 | signal |
| 48 | Blood Cholesterol Increased | 91 | 24.1 | 25.5 | signal |
| 49 | Pregnancy | 39 | 23.9 | 24.4 | signal |
| 50 | Night Sweats | 61 | 23.4 | 24.3 | signal |
| 51 | Red Blood Cell Sedimentation Rate Increased | 21 | 23.4 | 23.7 | signal |
| 52 | Psoriatic Arthropathy | 75 | 23.1 | 24.1 | signal |
| 53 | Colitis Ulcerative | 83 | 23.0 | 24.2 | signal |
| 54 | Knee Arthroplasty | 38 | 22.5 | 23.0 | signal |
| 55 | Swelling | 169 | 22.4 | 24.8 | signal |
| 56 | Sleep Disorder | 126 | 22.3 | 24.0 | signal |
| 57 | Road Traffic Accident | 74 | 21.9 | 22.8 | signal |
| 58 | Sinusitis | 179 | 21.5 | 24.0 | signal |
| 59 | Feeling Hot | 103 | 20.8 | 22.0 | signal |
| 60 | White Blood Cell Count Increased | 64 | 20.6 | 21.3 | signal |
| 61 | Liver Disorder | 71 | 19.8 | 20.6 | signal |
| 62 | General Physical Health Deterioration | 184 | 19.8 | 22.1 | signal |
| 63 | Rectal Haemorrhage | 67 | 19.2 | 20.0 | signal |
| 64 | Rheumatoid Arthritis | 172 | 18.8 | 20.8 | signal |
| 65 | Joint Swelling | 180 | 18.5 | 20.6 | signal |
| 66 | Lung Disorder | 73 | 18.4 | 19.2 | signal |
| 67 | Musculoskeletal Pain | 74 | 17.3 | 18.1 | signal |
| 68 | Inflammation | 71 | 17.1 | 17.8 | signal |
| 69 | Maternal Exposure During Pregnancy | 121 | 17.0 | 18.2 | signal |
| 70 | Osteoarthritis | 58 | 16.9 | 17.4 | signal |
| 71 | Prescribed Underdose | 27 | 16.7 | 17.0 | signal |
| 72 | Confusional State | 219 | 16.7 | 19.1 | signal |
| 73 | Amnesia | 87 | 16.5 | 17.3 | signal |
| 74 | Infection | 186 | 16.0 | 17.8 | signal |
| 75 | Alopecia | 250 | 15.7 | 18.2 | signal |
| 76 | Osteoporosis | 52 | 15.6 | 16.1 | signal |
| 77 | Hypersensitivity | 232 | 15.5 | 17.8 | signal |
| 78 | Abdominal Discomfort | 207 | 15.3 | 17.3 | signal |
| 79 | Wheezing | 72 | 15.0 | 15.7 | signal |
| 80 | Febrile Neutropenia | 79 | 14.7 | 15.4 | signal |
| 81 | Oedema | 64 | 14.6 | 15.1 | signal |
| 82 | Peripheral Swelling | 179 | 14.4 | 16.0 | signal |
| 83 | Dry Mouth | 94 | 14.3 | 15.1 | signal |
| 84 | Pancreatitis | 61 | 14.2 | 14.7 | signal |
| 85 | Respiratory Depression | 14 | 14.1 | 14.2 | signal |
| 86 | Madarosis | 13 | 13.7 | 13.8 | signal |
| 87 | Arthritis | 86 | 13.5 | 14.2 | signal |
| 88 | Mobility Decreased | 78 | 13.5 | 14.1 | signal |
| 89 | Joint Stiffness | 28 | 13.2 | 13.4 | signal |
| 90 | Gait Inability | 35 | 13.1 | 13.3 | signal |
| 91 | Loss Of Personal Independence In Daily Activities | 50 | 13.0 | 13.4 | signal |
| 92 | Respiratory Disorder | 30 | 12.4 | 12.6 | signal |
| 93 | Cytokine Release Syndrome | 19 | 12.3 | 12.5 | signal |
| 94 | Asthma | 109 | 12.0 | 12.8 | signal |
| 95 | Hair Colour Changes | 12 | 11.8 | 11.9 | signal |
| 96 | Nasopharyngitis | 175 | 11.7 | 12.9 | signal |
| 97 | Therapeutic Product Effect Decreased | 42 | 11.7 | 12.0 | signal |
| 98 | Therapy Non-responder | 42 | 11.6 | 11.9 | signal |
| 99 | Flushing | 93 | 11.3 | 11.9 | signal |
| 100 | Hair Texture Abnormal | 12 | 11.0 | 11.1 | signal |
| 101 | Inappropriate Antidiuretic Hormone Secretion | 9 | 10.9 | 11.0 | signal |
| 102 | Dyspepsia | 83 | 10.5 | 10.9 | signal |
| 103 | Weight Increased | 182 | 10.1 | 11.2 | signal |
| 104 | Musculoskeletal Stiffness | 71 | 10.0 | 10.4 | signal |
| 105 | C-reactive Protein Increased | 28 | 9.5 | 9.7 | signal |
| 106 | Neutrophil Count Decreased | 31 | 9.5 | 9.6 | signal |
| 107 | Migraine | 69 | 9.0 | 9.3 | signal |
| 108 | Incorrect Route Of Product Administration | 12 | 8.8 | 8.9 | signal |
| 109 | Chest Pain | 130 | 8.7 | 9.3 | signal |
| 110 | Muscular Weakness | 79 | 8.6 | 9.0 | signal |
| 111 | Pancreatitis Acute | 15 | 8.3 | 8.4 | signal |
| 112 | Insomnia | 176 | 8.2 | 9.0 | signal |
| 113 | Exposure During Pregnancy | 41 | 8.1 | 8.3 | signal |
| 114 | Condition Aggravated | 195 | 8.0 | 8.9 | signal |
| 115 | Treatment Failure | 53 | 8.0 | 8.2 | signal |
| 116 | Pyrexia | 223 | 8.0 | 9.0 | signal |
| 117 | Oesophagitis | 7 | 7.9 | 7.9 | signal |
| 118 | Abdominal Pain | 148 | 7.9 | 8.5 | signal |
| 119 | Hypoaesthesia | 95 | 7.8 | 8.2 | signal |
| 120 | Throat Tightness | 17 | 7.8 | 7.8 | signal |
| 121 | Hospice Care | 6 | 7.5 | 7.5 | signal |
| 122 | Pneumocystis Jirovecii Pneumonia | 6 | 7.4 | 7.4 | signal |
| 123 | Pneumonitis | 16 | 7.3 | 7.4 | signal |
| 124 | Hypomagnesaemia | 8 | 7.1 | 7.2 | signal |
| 125 | Small Intestinal Obstruction | 7 | 7.0 | 7.1 | signal |
| 126 | Dyspnoea | 321 | 7.0 | 8.4 | signal |
| 127 | Back Injury | 6 | 6.8 | 6.9 | signal |
| 128 | Anaphylactic Reaction | 30 | 6.7 | 6.9 | signal |
| 129 | Pruritus | 205 | 6.7 | 7.5 | signal |
| 130 | Leukopenia | 27 | 6.7 | 6.8 | signal |
| 131 | Arthralgia | 224 | 6.7 | 7.5 | signal |
| 132 | Thrombocytopenia | 60 | 6.6 | 6.9 | signal |
| 133 | Drug Hypersensitivity | 104 | 6.6 | 7.0 | signal |
| 134 | Memory Impairment | 73 | 6.6 | 6.8 | signal |
| 135 | Visual Impairment | 64 | 6.4 | 6.6 | signal |
| 136 | Underdose | 38 | 6.4 | 6.5 | signal |
| 137 | Chest Discomfort | 53 | 6.4 | 6.6 | signal |
| 138 | Neurotoxicity | 9 | 6.4 | 6.4 | signal |
| 139 | Retching | 11 | 6.4 | 6.4 | signal |
| 140 | Abdominal Pain Upper | 104 | 6.3 | 6.6 | signal |
| 141 | Disability | 10 | 6.2 | 6.3 | signal |
| 142 | Neutropenia | 66 | 6.0 | 6.2 | signal |
| 143 | Urticaria | 81 | 6.0 | 6.3 | signal |
| 144 | Drug-induced Liver Injury | 15 | 6.0 | 6.1 | signal |
| 145 | Muscle Spasticity | 6 | 6.0 | 6.0 | signal |
| 146 | Pericardial Effusion | 11 | 5.9 | 5.9 | signal |
| 147 | Medication Error | 26 | 5.8 | 5.9 | signal |
| 148 | Unresponsive To Stimuli | 12 | 5.8 | 5.8 | signal |
| 149 | Paraesthesia | 73 | 5.7 | 5.9 | signal |
| 150 | Mucosal Inflammation | 12 | 5.7 | 5.7 | signal |
| 151 | Rash | 194 | 5.5 | 6.1 | signal |
| 152 | Muscle Spasms | 81 | 5.5 | 5.7 | signal |
| 153 | Epilepsy | 13 | 5.3 | 5.3 | signal |
| 154 | Cytopenia | 5 | 5.2 | 5.2 | signal |
| 155 | Upper Gastrointestinal Haemorrhage | 7 | 5.1 | 5.1 | signal |
| 156 | Palmar-plantar Erythrodysaesthesia Syndrome | 8 | 4.2 | 4.2 | signal |
| 157 | Adverse Event | 31 | 4.2 | 4.2 | signal |
| 158 | Metastases To Central Nervous System | 4 | 3.9 | 3.9 | signal |
| 159 | Coeliac Disease | 3 | 3.8 | 3.8 | no signal |
| 160 | Inflammatory Bowel Disease | 3 | 3.8 | 3.8 | no signal |
| 161 | Diabetic Ketoacidosis | 7 | 3.6 | 3.6 | signal |
| 162 | Pelvic Pain | 5 | 3.4 | 3.4 | signal |
| 163 | Malignant Neoplasm Progression | 22 | 2.7 | 2.7 | signal |
| 164 | Neoplasm Progression | 7 | 2.5 | 2.5 | signal |
| 165 | Myelosuppression | 5 | 1.8 | 1.8 | no signal |